DS-6157

N/A

Report date: 2024/02/18 20:00:30

Base Information

Drug NameDS-6157

Drug Alias NameDS-6157a

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > Tetrapeptide linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Exatecan payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionAnti-GPR20

TargetsG-protein coupled receptor 20

Therapy Area/IndicationsGastrointestinal Stromal Tumors

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesJapan

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesDaiichi Sankyo Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesDaiichi Sankyo Co Ltd

Active IndicationsN/A

Inactive IndicationsGastrointestinal Stromal Tumors

Other Information

ATC CodeN/A